0001571049-15-010022.txt : 20151216
0001571049-15-010022.hdr.sgml : 20151216
20151216210054
ACCESSION NUMBER: 0001571049-15-010022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151214
FILED AS OF DATE: 20151216
DATE AS OF CHANGE: 20151216
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP
CENTRAL INDEX KEY: 0001069899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 131840497
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
BUSINESS PHONE: 201-329-7300
MAIL ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
FORMER COMPANY:
FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC
DATE OF NAME CHANGE: 19980908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Larry Lee
CENTRAL INDEX KEY: 0001603584
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36410
FILM NUMBER: 151292154
MAIL ADDRESS:
STREET 1: 8 HAZELWOOD COURT
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER NAME:
FORMER CONFORMED NAME: Miller Larry Lars
DATE OF NAME CHANGE: 20140325
4
1
t1502959_miller-f4.xml
OWNERSHIP DOCUMENT
X0306
4
2015-12-14
0
0001069899
PHIBRO ANIMAL HEALTH CORP
PAHC
0001603584
Miller Larry Lee
300 FRANK W. BURR BLVD., STE 21
TEANECK
NJ
07666-6712
0
1
0
0
President, Animal Health
Class A Common Stock
2015-12-14
4
M
0
23910
11.83
A
23910
D
Class A Common Stock
2015-12-14
4
S
0
23910
30.74
D
0
D
Class A Common Stock
2015-12-15
4
M
0
36090
11.83
A
36090
D
Class A Common Stock
2015-12-15
4
S
0
36090
31.00
D
0
D
Option to purchase Class A Common Stock
11.83
2015-12-14
4
M
0
23910
0
D
2012-03-01
2019-02-28
Class A Common Stock
23910
528590
D
Option to purchase Class A Common Stock
11.83
2015-12-15
4
M
0
36090
0
D
2012-03-01
2019-02-28
Class A Common Stock
36090
492500
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2015.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.28 to $31.28, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.61 to $31.29, inclusive.
This amount reflects the aggregate number of options to purchase Class A Common Stock with an expiration date of February 28, 2019 beneficially owned by the Reporting Person. Previously, the Reporting Person reported such options on different rows of Table II based on the applicable Exercisable Date.
/s/ Thomas G. Dagger, as Attorney-in-Fact for Larry L. Miller
2015-12-16